ZYDUSLIFE - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.5
| Stock Code | ZYDUSLIFE | Market Cap | 88,245 Cr. | Current Price | 876 ₹ | High / Low | 1,059 ₹ |
| Stock P/E | 18.8 | Book Value | 215 ₹ | Dividend Yield | 1.26 % | ROCE | 30.6 % |
| ROE | 31.1 % | Face Value | 1.00 ₹ | DMA 50 | 908 ₹ | DMA 200 | 935 ₹ |
| Chg in FII Hold | -0.28 % | Chg in DII Hold | 0.22 % | PAT Qtr | 343 Cr. | PAT Prev Qtr | 1,157 Cr. |
| RSI | 40.0 | MACD | -3.53 | Volume | 3,80,642 | Avg Vol 1Wk | 6,43,861 |
| Low price | 795 ₹ | High price | 1,059 ₹ | PEG Ratio | 0.26 | Debt to equity | 0.35 |
| 52w Index | 30.7 % | Qtr Profit Var | -27.2 % | EPS | 46.2 ₹ | Industry PE | 27.2 |
📊 ZYDUSLIFE shows moderate potential for swing trading. The RSI at 40.0 indicates neutral momentum, while the MACD is negative (-3.53), reflecting weak signals. The stock is trading below both its 50 DMA (908 ₹) and 200 DMA (935 ₹), showing technical weakness. Valuation is attractive (P/E 18.8 vs industry 27.2), and fundamentals are strong with ROCE at 30.6% and ROE at 31.1%. Quarterly profits declined sharply (343 Cr. vs 1,157 Cr.), but EPS at 46.2 ₹ and a PEG ratio of 0.26 suggest growth-adjusted value. Institutional activity is mixed, with FIIs reducing (-0.28%) and DIIs increasing (+0.22%). Overall, this is a cautious but promising swing candidate.
💡 Optimal Entry Price: Around 860–880 ₹ (near support zone above 795 ₹).
📈 Exit Strategy if Holding: Consider exiting near 905–920 ₹ (close to 50 DMA resistance) unless momentum strengthens further.
Positive
- Strong ROCE (30.6%) and ROE (31.1%) show excellent efficiency.
- Valuation is attractive compared to industry (P/E 18.8 vs 27.2).
- EPS at 46.2 ₹ supports valuation stability.
- PEG ratio of 0.26 suggests strong growth-adjusted valuation.
- Dividend yield of 1.26% provides shareholder returns.
Limitation
- Stock trading below DMA 50 and DMA 200, showing bearish technicals.
- MACD negative (-3.53), reflecting weak momentum.
- Quarterly PAT declined sharply (343 Cr. vs 1,157 Cr.).
- Volumes below weekly average, showing reduced trader interest.
Company Negative News
- FII holdings reduced (-0.28%), showing weaker foreign investor confidence.
- Quarterly profit variation (-27.2%) highlights earnings pressure.
Company Positive News
- DII holdings increased (+0.22%), showing domestic institutional support.
- Strong fundamentals with high ROCE and ROE.
- Valuation remains attractive compared to peers.
Industry
- Industry P/E at 27.2 is higher than ZYDUSLIFE’s, suggesting undervaluation.
- Pharma sector remains stable with long-term growth potential.
Conclusion
⚖️ ZYDUSLIFE is fundamentally strong with attractive valuation and institutional support, but technically weak with declining profits. While a short-term bounce is possible, risk remains due to bearish signals. Entry near 860–880 ₹ with an exit around 905–920 ₹ is advisable, but strict risk management is essential.